Robert Giugliano - Dissemin

All papers authored by Robert Giugliano

This paper was not found in any repository, but could be made available legally by the author.

2023 Josephine Harrington

, Anthony P. Carnicelli

, Kaiyuan Hua

, Lars Wallentin

, Manesh R. Patel

, Stefan H. Hohnloser

, Robert P. Giugliano

, Keith A. A. Fox

, Ziad Hijazi

, Renato D. Lopes

, Sean D. Pokorney

, Hwanhee Hong, Christopher B. Granger

Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF

Upload

This paper is made freely available by the publisher.

2022 Christopher B. Fordyce

, Robert P. Giugliano

, Christopher P. Cannon, Matthew T. Roe, Abhinav Sharma

, Courtney Page, Jennifer A. White, Yuliya Lokhnygina, Eugene Braunwald

, Michael A. Blazing

Cardiovascular Events and Long‐Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE‐IT

Download from doi.org

2021 Marc P. Bonaca

, Elliott M. Antman

, Jonathan W. Cunningham

, Stephen D. Wiviott, Sabina A. Murphy, Jonathan L. Halperin, Jeffrey I. Weitz, Michael A. Grosso, Hans J. Lanz, Eugene Braunwald

, Robert P. Giugliano

, Christian T. Ruff

Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48

Upload

Emily S. Lau, Eugene Braunwald

, David A. Morrow

, Robert P. Giugliano

, Elliott M. Antman, C. Michael Gibson, Benjamin M. Scirica

, Erin A. Bohula, Stephen D. Wiviott

, Deepak L. Bhatt

, Marc P. Bonaca

, Christopher P. Cannon, KyungAh Im, Jianping Guo, Marc S. Sabatine

and 1 other authors

Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials

Upload

2020 Anna Plitt, Thomas A. Zelniker, Jeong-Gun Park, Darren K. McGuire, Christian T. Ruff, Elliott M. Antman, Eugene Braunwald

, Robert P. Giugliano

Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trials

Upload

2019 Eri Toda Kato, Shinya Goto, Robert P. Giugliano

Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation

Upload

2018 Marc P. Bonaca, J. Antonio Gutierrez, Christopher Cannon, Robert Giugliano

, Michael Blazing, Jeong-Gun Park, Jennifer White, Andrew Tershakovec, Eugene Braunwald

Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial

Upload

Tracey G. Simon, Kathleen E. Corey, Christopher P. Cannon, Michael Blazing, Jeong-Gun Park, Michelle L. O'Donoghue, Raymond T. Chung, Robert P. Giugliano

The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe

Upload

Alberto Aimo, Robert P. Giugliano

, Raffaele De Caterina

Non–Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves

Upload

David D. Berg, Stephen D. Wiviott, Eugene Braunwald, Jianping Guo, KyungAh Im, Amir Kashani, C. Michael Gibson, Christopher P. Cannon, David A. Morrow, Deepak L. Bhatt, Jessica L. Mega, Michelle L. O’Donoghue, Elliott M. Antman, L. Kristin Newby, Marc S. Sabatine and 1 other authors

Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials

Upload

Ramón Corbalán, José Carlos Nicolau, José López-Sendon, Armando Garcia-Castillo, Rodrigo Botero, Gustavo Sotomora, Manuel Horna, Christian T. Ruff, Rose A. Hamershock, Laura T. Grip, Elliott M. Antman, Eugene Braunwald, Robert P. Giugliano

Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Marc S. Sabatine, Stephen D. Wiviott, KyungAh Im, Sabina A. Murphy, Robert P. Giugliano

Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels

Upload

Christina L. Fanola, Christian T. Ruff, Sabina A. Murphy, James Jin, Anil Duggal, Noe A. Babilonia, Piyamitr Sritara, Michele F. Mercuri, Pieter W. Kamphuisen, Elliott M. Antman, Eugene Braunwald, Robert P. Giugliano

Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial

Download from doi.org

Marc S. Sabatine, Gaetano M. De Ferrari, Robert P. Giugliano

, Kurt Huber, Basil S. Lewis, Jorge Ferreira, Julia F. Kuder, Sabina A. Murphy, Stephen D. Wiviott, Christopher E. Kurtz, Narimon Honarpour, Anthony C. Keech, Peter S. Sever, Terje R. Pedersen

Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease

Upload

Jose C. Nicolau, Remo H. M. Furtado, Luciano M. Baracioli, Livia M. Lara, Talia F. Dalçóquio, Marco A. Scanavini Junior, César A. C. Pereira, Viviane M. Lima, Talita M. Gonçalves, Raíza Colodetti, Aline G. Ferrari, Renato D. Lopes, Robert P. Giugliano

The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up Study

Upload

Seth S. Martin, Robert P. Giugliano

, Sabina A. Murphy, Scott M. Wasserman, Evan A. Stein, Richard Ceška, José López-Miranda

, Borislav Georgiev, Alberto J. Lorenzatti, Matti J. Tikkanen, Peter S. Sever, Anthony C. Keech, Terje R. Pedersen, Marc S. Sabatine

Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation

Upload

Erin A. Bohula, Robert P. Giugliano

, Lawrence A. Leiter, Subodh Verma, Jeong-Gun Park, Peter S. Sever, Armando Lira Pineda, Narimon Honarpour, Huei Wang, Sabina A. Murphy, Anthony Keech, Terje R. Pedersen, Marc S. Sabatine

Inflammatory and Cholesterol Risk in the FOURIER Trial

Upload

Ophelia Q. P. Yin, Elliott M. Antman, Eugene Braunwald, Michele F. Mercuri, Raymond Miller, David Morrow, Christian T. Ruff, Kenneth Truitt, Jeffrey I. Weitz, Robert P. Giugliano

Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial

Upload

Vera A. Bittner, Robert P. Giugliano

, Eliot A. Brinton, John R. Guyton

PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease

Upload

Erin A. Bohula, Stephen D. Wiviott, Robert P. Giugliano

, Jeong-Gun Park, Sabina A. Murphy, Christopher P. Cannon, Eugene Braunwald

Response by Bohula et al to Letters Regarding Article, “Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)”

Download from circ.ahajournals.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Robert Giugliano